Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia
Altered metabolism is a hallmark of cancer. However, the role of genomic changes in metabolic genes driving the tumour metabolic shift remains to be elucidated. Here, we have investigated the genomic and transcriptomic changes underlying this shift across ten different cancer types.A systematic pan-...
主要な著者: | Haider, S, McIntyre, A, van Stiphout, R, Winchester, L, Wigfield, S, Harris, A, Buffa, F |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
BioMed Central
2016
|
類似資料
-
The tumour hypoxia induced non-coding transcriptome.
著者:: Choudhry, H, 等
出版事項: (2016) -
Gene expression signatures as biomarkers of tumour hypoxia
著者:: Harris, B, 等
出版事項: (2015) -
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
著者:: Jubb, A, 等
出版事項: (2010) -
The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer (TNBC)
著者:: Harris, A, 等
出版事項: (2016) -
Metabolic Shift and Hyperosmolarity Underlie Age-Related Macular Degeneration
著者:: Laurent Schwartz, 等
出版事項: (2024-09-01)